期刊
BIO-MEDICAL MATERIALS AND ENGINEERING
卷 25, 期 4, 页码 347-360出版社
IOS PRESS
DOI: 10.3233/BME-151539
关键词
Polycaprolactone; chitosan; scaffold; calvarium
The ability to repair bone defects of polycaprolactone-chitosan scaffolds containing 20% chitosan (PCL-20% CS) fabricated using the melt stretching and multilayer deposition (MSMD) technique was assessed and compared with commercial scaffolds. Two calvarium defects of 11 mm in diameter were created in each of the fifteen New Zealand white rabbits. The PCL-20% CS scaffolds were implanted in one site (group A) while another site was performed with PCL-tricalcium phosphate (TCP) scaffolds containing 20% TCP (PCL-20% TCP) fabricated by fused deposition modeling technique (FDM) (group B). At two, four and eight weeks thereafter, new bone regeneration within the defects was assessed using histomorphometric and micro-computed tomography (mu-CT) analysis. The result of histological sections demonstrated that chronic inflammatory reaction was generally detected along scaffolds of group A, but it was not found in group B. Over 8 weeks, the mu-CT analysis indicated that the average amount of new bone of group A was slightly less than that of group B (p > 0.05). In conclusion, efficacy of the PCL-20% CS MSMD scaffolds for repairing bone defects was less than that of the PCL-20% TCP FDM scaffolds. However, MSMD scaffolding is still the technique of choice, but needed some modifications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据